News + Filings Transactions
|
WEISS FRED G
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/27/2021 | RVL Pharmaceuticals plc | OSMT | Payment of Exercise | Ordinary Shares | 5.5k | $3.31 | $18.2k | | 08/27/2021 |
| 07/02/2021 | RVL Pharmaceuticals plc | OSMT | Grant | Ordinary Shares | 61.2k | $0.00 | $0 | | 07/02/2021 |
| 06/18/2021 | RVL Pharmaceuticals plc | OSMT | Payment of Exercise | Ordinary Shares | 18.6k | $2.89 | $53.7k | | 06/18/2021 |
| 01/24/2021 | RVL Pharmaceuticals plc | OSMT | Payment of Exercise | Ordinary Shares | 5.5k | $4.46 | $24.6k | | 01/24/2021 |
| 05/21/2020 | RVL Pharmaceuticals plc | OSMT | Payment of Exercise | Ordinary Shares | 17.8k | $4.60 | $81.8k | | 05/20/2020 |
| 05/20/2020 | RVL Pharmaceuticals plc | OSMT | Grant | Ordinary Shares | 38.7k | $0.00 | $0 | | 05/20/2020 |
| 01/28/2020 | RVL Pharmaceuticals plc | OSMT | Payment of Exercise | Ordinary Shares | 5.5k | $7.00 | $38.5k | | 01/28/2020 |
| 06/18/2019 | RVL Pharmaceuticals plc | OSMT | Grant | Ordinary Shares | 37k | $0.00 | $0 | | 06/18/2019 |
| 01/24/2019 | RVL Pharmaceuticals plc | OSMT | Grant | Ordinary Shares | 34.4k | $0.00 | $0 | | 01/24/2019 |
| 05/02/2018 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 2k | $151.07 | $299.9k | | 05/02/2018 |
| 05/04/2017 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 1.2k | $245.25 | $299.9k | | 05/03/2017 |
| 05/03/2017 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 668 | $243.76 | $162.8k | | 05/03/2017 |
| 08/08/2016 | Allergan plc | AGN | Grant | Ordinary shares, par value $0.0001 | 201 | $248.31 | $49.9k | | 08/08/2016 |
| 05/05/2016 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 1.2k | $210.34 | $249.9k | | 05/05/2016 |
| 06/05/2015 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 826 | $302.30 | $249.7k | | 06/04/2015 |
| 06/05/2015 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 826 | $302.30 | $249.7k | | 06/05/2015 |
| 06/04/2015 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 549 | $303.38 | $166.6k | | 06/04/2015 |
| 06/04/2015 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 549 | $303.38 | $166.6k | | 06/05/2015 |
| 05/09/2014 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 1.1k | $197.05 | $225k | | 05/09/2014 |
| 11/14/2013 | Allergan plc | AGN | Sale | Ordinary Shares | 3k | $164.15 | $492.4k | | 11/14/2013 |
| 10/01/2013 | Allergan plc | AGN | Grant | Ordinary Shares | 27.3k | $0.00 | $0 | | 10/01/2013 |
| 07/30/2012 | Actavis, Inc. | ACT | Exercise | Non-Qualified Options to Purchase Common Stock | 30k | $36.57 | $1.1M | | 07/30/2012 |
| 07/30/2012 | Actavis, Inc. | ACT | Sale | Common Stock, par value $0.0033 | 30k | $78.78 | $2.4M | | 07/30/2012 |
| 05/11/2012 | Actavis, Inc. | ACT | Grant | Common Stock, par value $0.0033 | 2.9k | $0.00 | $0 | | 05/11/2012 |
|